Roselabs Finance Ltd.

As of June 30, 2026, Roselabs Finance Ltd. carries a market capitalization of 205.00M, placing it among publicly traded companies globally. Its enterprise value stands at 205.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Roselabs Finance Ltd. has 10.00M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 16.98 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 205.00M versus a market cap of 205.00M, with the gap driven by net debt and cash on the balance sheet.

Over the twelve months ended June 30, 2026, Roselabs Finance Ltd. recorded 1.09M in income tax expense. The company reported a pretax loss of -1.93M and -3.02M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Roselabs Finance Ltd.'s stock has declined approximately 37.42% over the past 52 weeks. The 50-day moving average sits at 20.92, while the 200-day moving average is 22.57.

Over the twelve months ended June 30, 2026, Roselabs Finance Ltd. generated 12.08M in revenue and converted that into -3.02M in net income, yielding earnings per share of -0.30. EBITDA reached -1.93M, while operating income came in at -1.93M.

Over the twelve months ended June 30, 2026, Roselabs Finance Ltd. posted a gross margin of 0.99, reflecting its pricing power and cost economics. The operating margin of -15.96 and net profit margin of -25.00 provide insight into operational efficiency.